Follow the 올리패스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 올리패스 has published 2 insider filings. Market capitalisation: €13.4bn. The latest transaction was filed on 7 April 2026 (Purchase). Among the most active insiders: 유명희. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
올리패스 是一家在XKRX市场上市的医疗保健和制药公司。它专注于创新疗法和治疗解决方案的开发。